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Infants born prematurely are often discharged from hospital before 37 weeks post 
menstrual age. While breastfeeding will meet all the nutritional requirements of full-
term infants, these preterm infants may need enhanced levels of protein, minerals and 
possibly energy to ensure optimum growth, bone mineralisation and neurological 
development. To meet these additional nutrient needs in the neonatal unit, it is 
currently recommended that multinutrient breast milk fortifier is added to maternal 
breast milk. There may also be benefits in continuing to provide fortified milk after 
discharge, potentially including improved growth and preserving breastfeeding, and 
this is increasingly becoming a recognised practice in some neonatal units. This article 
presents the discussion and consensus of a multidisciplinary panel of neonatologists, 
neonatal dietitians, a GP and a neonatal outreach nurse. The aim is to develop guidance 
on providing safe and effective nutritional supplementation for preterm infants after 
discharge in order to maintain optimal growth. This guidance is aimed at community 
healthcare staff and is based on the limited evidence available, using shared best 




Preterm infants, particularly those weighing less than 1800 g at birth, have higher nutritional 
requirements than those born at term. This is because current recommendations (Ehrenkranz, 
2014) aim to promote rates of growth and tissue accretion similar to that which would be 
achieved in utero at the same gestation. To this end, current European guidelines (Agostini et 
al, 2010; Koletzko et al, 2014; Moro et al, 2015; Arslanoglu et al, 2019) recommend that 
preterm infants born weighing less than 1800 g who are receiving milk feeds receive 
additional nutritional supplementation. For infants receiving maternal breast milk or donor 
breast milk, supplementation usually takes the form of a multicomponent breast milk 
fortifier, whilst those receiving formula milk should receive specialist preterm infant formula. 
The use of breast milk fortifier during hospital stay has been shown to help maintain head 
growth, length and weight gain and better overall nutritional status (O’Connor et al, 2008; 
Aimone et al, 2009; Brown et al, 2020), although the longer term benefits are unclear 
(Toftlund et al, 2018). There is also some evidence for improved visual and lung function 
(O’Connor et al, 2012; Toftlund et al, 2019). It should be noted that breastfeeding, or feeding 
with mother’s own expressed breastmilk, is the best option for all low birth-weight infants 
(Edmond and Bahl, 2006). 
Current recommendations also suggest that preterm infants who receive formula milk and 
who have failed to ‘catch up’ on the unit should be transitioned over to a specialist post-
discharge preterm infant formula just before discharge with this continued for several weeks 
thereafter, in order to maintain higher nutrient intakes. However, there is currently no such 
recommendation for infants receiving fortified breast milk; these infants tend to stop 
receiving fortifier while establishing oral breastfeeds and so are discharged home 
breastfeeding without supplementation. This means that breastfed low birth weight infants 
receive a lower nutrient intake around the time of discharge, at a time when their sleep/wake 
pattern and possibly oral motor maturity is not fully developed, meaning that upregulating 
volume may be difficult, putting them at risk of poor growth. It is currently not standard 
practice to continue providing breast milk fortifier to the parents of these smaller infants after 
discharge, although there is some evidence to suggest that this can produce sustained 
improvements in various growth parameters (O’Connor et al, 2008; Aimone et al, 2009; 
Zachariassen et al, 2011; Marino et al, 2019). Providing breast milk fortifier to these infants 
around the time of discharge and beyond offers a way to try and ensure they receive adequate 
nutrition and achieve optimal growth. It may help prevent growth failure beyond discharge 
and this is important as poor growth can lead to mothers losing confidence in breastfeeding 
and prompt healthcare professionals to advise supplementing with formula feeds.  
However, there are also potential hazards in promoting excessive growth. There is some 
evidence for an increased risk of insulin resistance or cardiovascular disease in later life in 
infants who undergo excessive weight gain and who may increase across weight percentiles 
in their first few months (Euser et al, 2005, 2008; Singhal et al, 2007). It is therefore 
important to monitor weight gain closely to ensure growth velocity is appropriate when using 
nutritional supplements beyond discharge. There are also concerns about the effects on the 
mother’s willingness to continue breastfeeding if she adopts the view that her own milk is not 
adequately meeting the infant’s needs. However, there is some evidence that use of fortifier 
beyond discharge does not reduce duration of breastfeeding (O’Connor et al, 2008; 
Zachariassen et al, 2011; King, 2014). 
Which infants should receive fortified human breast milk? 
 3 
It is important to clearly define which infants should receive fortified human breast milk. 
There is variation in local guidelines used around the country, but the panel proposes that 
infants born before 32 weeks’ gestation and/or preterm infants weighing less than 1800 g 
should be considered suitable for ongoing fortification of maternal breast milk after 
discharge. A weight criterion of 1800g was also used in the ESPGHAN (European Society of 
Paediatric Gastroenterology, Hepatology and Nutrition) recommendations (Agostini et al, 
2010). In addition, fortification should also be considered for infants whose growth 
parameters fall down more than 1.33 standard deviations (equivalent to crossing two marked 
centile lines) on a UK newborn infant close monitoring (NICM) growth chart (this may be 
termed faltering growth, as per the National Institute for Health and Care Excellence (2020) 
quality standard).  
Neonatal units will usually discontinue fortification when the infant is ready to be discharged. 
However, with the extension of outreach services nationally, preterm infants are being 
discharged earlier, and it is becoming a practical option to maintain fortifier treatment at 
home (King, 2014; King and Winter, 2014; Marino et al, 2019). The panel felt that the 
fortification product should be prescribed by hospital physicians rather than GPs, and 
monitored by the neonatal multidisciplinary team, at least while this remains a new area of 
practice. The hospital team will ensure that parents receive training in handling and 
administering the fortifier, which is mixed with expressed breast milk and delivered via a 
bottle, syringe or cup (depending on local practice), before the infant is discharged.  
Fortification provides vital nutrients needed during the period of rapid bone mineralisation as 
the infant approaches term. By this time, most preterm infants will have developed a mature 
sleep/wake pattern and oral reflexes which mean they will successfully breastfeed. Decisions 
on when to discontinue fortification are likely to reflect the specific features of each 
individual case, as well as local guidelines. In those units currently using fortifier beyond 
discharge, some will recommend reducing or stopping fortification at around 46 weeks 
corrected gestational age, while other centres continue up to 52 weeks corrected gestational 
age, and some will start the process of ceasing fortification only once infants have made any 
catch-up growth. The infant’s growth should be monitored using a UK NICM growth chart 
and fortification should be discontinued earlier if the weight crosses to a higher marked 
centile line which is out of proportion with length. Parents should be made aware that 
crossing down as much as a marked centile line on a UK NICM growth chart after beginning 
breastfeeding is not unusual. When the infant is able to maintain its weight along the same 
centile, it may be possible to reduce the dose of fortifier being administered. The infant’s 
weight should not be considered in isolation as other growth parameters such as the infant’s 
length and head circumference are equally as important. Both quantity and quality of growth 
need to be considered. 
In the UK, the SIFT Investigators (Dorling et al, 2019) found that over 97% of infants 
<32 weeks’ gestation or <1500 g at birth receive human milk in the first weeks of life with 
the majority receiving mother’s own milk. However, many infants will not be exclusively 
breast feeding at discharge, although they may still be receiving expressed breast milk. 
Mothers may be offered post-discharge preterm infant formula and it is important that they 
are made aware of the difference between post-discharge preterm infant formula, standard 
formula and human breast milk fortifier. Human breast milk fortifier is a supplement and not 
intended as a replacement for maternal milk, since it does not contain all the macro- and 
micronutrients needed for healthy growth. Its use is intended to supply extra protein, minerals 
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and vitamins, and a little energy to enable the preterm infant to grow in a way that would 
approximate that seen in utero. 
It should be noted that breastfeeding, or feeding with mother’s own expressed breastmilk, is 
the best option for all low birth-weight infants (Edmond and Bahl, 2006). Partial 
breastfeeding at discharge, low maternal educational level and longer length of stay in the 
neonatal intensive care unit all increase the risk for ceasing breastfeeding during the first 
12 months (Maayan-Metzger et al, 2018). There is some evidence to suggest that providing 
fortifier to supplement breast milk does not decrease the duration of breastfeeding, possibly 
because of the increased level of lactation support (O’Connor et al, 2008), and may possibly 
support it (King, 2014). However, it may be because infants receiving post-discharge fortifier 
do not have weight faltering, meaning that the addition of formula is not recommended by 
health professionals monitoring infants’ growth post discharge. Continued breastfeeding will 
have positive long-term health consequences in terms of hospital readmissions, minor 
infections and cardiovascular disease among others, and in turn will have health economic 
benefits (Renfrew et al, 2012). 
If, despite continued use of breast milk fortifier, an ex-preterm infant’s growth appears to be 
faltering at 48 weeks corrected gestational age, a referral should be made for a full nutritional 
review with the local neonatal or paediatric dietitian, along with support and education from 
community services to support continued breastfeeding. At this stage other factors may be 
responsible for the faltering and breast milk fortifier may not be an appropriate treatment.  
 
The role of different healthcare professionals  
 
Close monitoring and regular follow up is required for all infants discharged on breast milk 
fortifier to ensure they are continuing to exhibit satisfactory growth. Infants on breast milk 
fortifier in the community will need regular follow up to monitor growth and tolerance, and 
advice on reducing dose. However, if a preterm infant is discharged at 34–38 weeks corrected 
gestational age they should receive earlier follow up to review feeding progression and 
growth. This follow up can be done by neonatal outreach teams, dietitians, community nurses 
or health visitors – increasingly this care will be provided by the neonatal unit’s outreach 
staff along with their neonatal dietitian. However, in areas where these services are not yet 
available, community nursing staff or health visitors are advised to weigh and measure the 
infant at weekly intervals and relay that information to the neonatal or paediatric consultant 
and the dietitian on the neonatal unit, if available. 
If growth appears to be faltering during this initial 6–8-week period, then it is recommended 
that the infant should be referred to a neonatal or paediatric dietitian, and for an assessment of 
breastfeeding technique and the mother’s lactation. Staff at the hospital neonatal unit and/or 
the neonatal outreach team may provide advice to community health professionals, such as 
the ‘healthy families team’, but the GP practice will be responsible for routine care. Parents 
with urgent concerns over their infant’s health (other than growth or feeding) should contact 
their GP surgery or hospital emergency department rather than seeking guidance from the 
neonatal unit, since these facilities will not normally re-admit patients after they have been 
discharged. Most infants who fit the criteria to receive breast milk fortifier will receive follow 
up with a neonatologist or paediatrician until they are 2 years of age. Health visitors and GPs 
will have a responsibility for routine monitoring of health, growth, development and any 
illnesses, but most infants will also be in a neonatal follow-up programme. 
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Supporting breastfeeding at home 
Preterm infants may be at risk of faltering growth at home as a result of persistent immature 
feeding patterns related to the prematurity of the infant, which should improve over time. It is 
possible that mothers of these infants may become disheartened with breastfeeding if the 
infant fails to grow and may consider switching to, or supplementing with, formula milk. 
Therefore, adding fortifier, which provides additional protein and nutrients to support the 
infant’s growth, may encourage mothers to maintain breastfeeding. The process of expressing 
breast milk and mixing in the powdered fortifier may be difficult and time consuming for 
many mothers, so they will need simple but specific written advice with details of who to 
contact with queries, as well as support and encouragement from both dietetic and outreach 
services.  
 
Dosage and administration of fortifier 
 
Currently two breast milk fortifier products are available and used for home fortification in 
the UK: Nutriprem Human Milk Fortifier (Nutriprem HMF) and SMA Breast Milk Fortifier 
(SMA BMF). Of note, Nutriprem HMF sachets contain approximately twice the amount of 
fortifier as SMA HMF. There may be confusion regarding the names of these products, but it 
is important to remember that both products are made from hydrolysed cow’s milk.  
 
Normally, for use before hospital discharge, one sachet of Nutriprem HMF or two sachets of 
SMA BMF is added to each 50 ml expressed breast milk. However, for home use the fortifier 
is added to smaller measured volumes of expressed breast milk and given to the infant 
alongside some breastfeeds throughout the day. The resulting fortifier solution is more 
concentrated than the standard dilution used before hospital discharge. For the purposes of 
this document, use of either product is referred to as ‘BMF concentrate’.  
 
The total number of sachets of fortifier to be used daily will vary according to the needs of 
the individual infant and the product used. In practice the amount of BMF concentrate per 
day is typically based on 50% of that which would have been required to fortify 
approximately 150 ml/kg/day at the infant’s discharge weight. The quantity of BMF 
concentrate prescribed at discharge is usually continued until the infant is following a weight 
centile line; after which the daily quantity of BMF concentrate should be reduced gradually, 
for example, by one BMF concentrate per day per week until no further fortifier is required. 
Dietetic staffing to support these infants following discharge from hospital varies throughout 
the country, as does the approach to reducing and stopping fortifier. As a guide, BMF 
concentrate should not usually be required after term plus 6 weeks corrected age; further 
dietetic assessment should be sought if growth remains a concern at this time. 
 
Ideally, BMF concentrate should be made as close as possible to the time of the feed. Figure 
1 gives an example of how to make up individual BMF concentrate using both products 
currently available in the UK, although local policy should be followed if such practice 
differs. 
 
Figure 1. Examples of how to make up breast milk fortifier (BMF) concentrate using 
currently available breast milk fortifiers. This information is based on practice developed at 
Queen Charlottes Neonatal Unit, London. 
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For Nutriprem HMF (one sachet is usually added to 50ml expressed breast milk) 
Example calculation for daily fortifier dosage with Nutriprem HMF for a 2.1 kg infant 
• One sachet Nutriprem HMF mixed with 3 ml expressed breast milk provides a 4 ml 
‘BMF concentrate’ 
2.1 kg infant feeding 150 ml/kg/day   =  315 ml per day 
315 ml ÷ 50 ml    =  6.3 sachets Nutriprem HMF per day 
50% requirement     =  3.1 sachets per day  
Using one sachet per BMF concentrate  =  Three Nutriprem BMF concentrate per 
day 
• Continue three Nutriprem BMF concentrate per day until weight is following a 
centile 
• Reduce by one Nutriprem BMF concentrate per day per week until nil concentrate 
is required 
For SMA BMF (one sachet is usually added to 25ml expressed breast milk) 
Example calculation for daily fortifier dosage with SMA HMF for a 2.1 kg infant 
• Two sachets SMA BMF mixed with 3 ml expressed breast milk provides a 4 ml 
BMF concentrate 
2.1 kg infant feeding 150 ml/kg/day   = 315 ml per day 
315 ml ÷ 25 ml    = 12.6 sachets SMA BMF per day 
50% requirement     = 6.3 sachets per day  
Using two sachets per BMF concentrate = Three SMA BMF concentrate per day  
• Continue three SMA BMF concentrate per day until weight is following a centile 




Table 1 provides the nutritional composition of the two products currently available in the 
UK and used for home fortification (macronutrients and a selection of micronutrients are 
included). The analysis is given per sachet and should be considered when comparing the 
products. 
 
Table 1. Nutritional composition (per sachet) of breast milk fortifiers (BMF) available 
in the UK 
Product Sachet 
size (g) 























Nutriprem HMF 2.2 8 0.6 1.4 0 18 12 33 19 0 0.31 116 
SMA BMF 1 4.3 0.36 0.32 0.18 9.2 12 19 11 0.45 0.24 95 
From Nutricia (2020), SMA Nutrition (2019)  
 
Parents should be warned that ‘more is not necessarily better’ when serving the nutritional 
needs of their preterm infant. The infant’s appetite and feeding behaviour will change as they 
reach full term age. The infant is likely to feed more frequently as its feeding skills and 
stamina mature, but mothers should not add extra fortifier beyond that recommended by the 
hospital, and should be reminded of the importance of following each BMF concentrate with 
a breast feed. BMF concentrate should not be given alongside formula feeds. Advice should 
be sought if mothers reduce or stop breast feeding any point during this treatment. 
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It is also important to note that SMA BMF contains more iron than Nutriprem HMF and this 
should be considered when prescribing iron supplementation. 
 
Guidance for parents 
 
Before taking their infant home, parents should be congratulated on having reached this stage 
of their breastfeeding journey. It should be emphasised how important breastfeeding will be 
in this process and how it can provide longer term benefits for both infant and mother if 
continued for as long as the mother and infant are able. It should be emphasised that while 
some preterm infants will thrive on breast milk alone, others may benefit from the time and 
effort taken by their parents to mix and administer the fortified maternal milk. 
 
Parents should appreciate that preterm infants who have reached an appropriate weight for 
their age may still face considerable health challenges. Moreover, all infants may experience 
common childhood illnesses that are completely unrelated to their developmental age. It is 
appropriate for parents to be given the contact details of the outreach team, dietetic team, or 
equivalent service, for advice on non-urgent issues related to the infant’s growth and the use 
and supply fortifier, which is normally supplied by the neonatal unit. It is important to advise 
parents of the potential implications of overnutrition. 
 
Priorities for further research 
Breast milk fortification is a major nutritional intervention with significant potential benefits 
for the infant concerned. There is a need for further research to provide high quality evidence 
on the long-term impact of this practice on the future health of preterm infants. In particular, 
questions remain about whether the use of breast milk fortifier around the time of discharge 
and beyond can improve both the quantity and quality of growth in preterm infants. 
Furthermore, whether any such improvements can lead to better neurodevelopmental 
outcomes is also key, and there is a need to consider the impact of such changes in growth in 
relation to the use of home fortifier regarding long-term cardiovascular health and the risk of 
metabolic disease in later life. Finally, as breastfeeding is associated with improvements in 
both short- and long-term health in all infants, the impact of home fortifier use on 
breastfeeding rates and duration needs to be formally evaluated. High quality randomised 
controlled trials are needed to address all these issues.  
Breast milk fortifiers are not currently prescribed by GPs. This group believe that the use of 
these products as described in this document, which is outside of the manufacturer 
recommendations, should be directed by staff within neonatal services and be limited to 
infants who remain under hospital follow up. 
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Key points 
• Current European guidelines recommend that preterm infants born weighing less than 
1800 g who are receiving milk feeds receive additional nutritional supplementation. 
For infants receiving breast milk, this may take the form of a multinutrient breast milk 
fortifier.  
• Fortification provides protein, minerals and vital micronutrients needed during the 
period of rapid bone mineralisation as the infant approaches normal term. 
• Continuing fortification after discharge from hospital aims to optimise growth and 
may help supporting breastfeeding during a time when infants are developing mature 
feeding skills. 
• Decisions on when to discontinue fortification are likely to reflect the specific 
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